Skip to Content

TAK ALG-25 (Nesina 25 mg)

Generic Name: alogliptin

Pill with imprint TAK ALG-25 is Red, Elliptical / Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-25

Nesina 25 mg TAK ALG-25

Nesina

Generic Name
alogliptin
Imprint
TAK ALG-25
Strength
25 mg
Color
Red
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
64764-0250 Takeda Pharmaceutical Company Limited
45802-0150 Perrigo Company

Get help with Imprint Code FAQs.

Related Images for "TAK ALG-25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.